Advances in Molecular Diagnostics for Nosocomial Infections (Technical Insights)


USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

This research service outlines the key developments taking place globally in the field of molecular-based testing for hospital acquired infections.

Table of Contents

Advances in Molecular Diagnostics for Nosocomial Infections (Technical Insights), Executive SummaryScope and MethodologyScopeMethodologyNosocomial Infections in FocusImpact of Nosocomial InfectionsThe Industry: SnapshotAdvances in Molecular Diagnostics for Nosocomial Infections (Technical Insights), Nosocomial Infections: A ForerunnerIntroduction and EpidemiologyIntroductionEpidemiology and Transmission of Hospital-Acquired InfectionsPredisposition and Infection PreventionPredisposition to InfectionPreventionAdvances in Molecular Diagnostics for Nosocomial Infections (Technical Insights), Technology Assessment in Corporate and Academic SectorsCorporate DevelopmentsAn Efficient Strain-Typing System for Effective Surveillance--FranceA Fully Automated Test for MRSA Surveillance--USAQuick PCR-Based Assay Paves the Way for Future Molecular Diagnostics--USAA Novel Technology that Uses Viruses to Detect Bacteria--USAA Fluorescence In Situ Hybridization-Based Technology for Diagnosis of Bloodstream Infections--USABedside Biosensors--USAA Handheld Microfluidic Diagnostic System--AustraliaA Novel Optical Mapping Instrument for Nosocomial Infection Diagnosis--USAA Rapid ELISA Test for Clostridium Difficile--USANanoLantern Biosensors--A Robust Tool for Pathogen Detection--USAAn Evolving Technique for Instant Multiple Drug-Resistant Bacterial Detection--USAHigh-Throughput Array Technique for Efficient and Faster Pathogen Detection--USADevelopments in AcademiaBroad Range of User-Friendly Advances in Molecular Diagnostics for Microbial Characterization--USAAssay Platform as a Powerful Tool for Biofilm Infections Identification--USALateral Flow Micro Arrays--Technological Advancement in Molecular Detection Platforms--USAPromising Diagnostic Technique for Prosthetic Joint Implant-Associated Infections--USAAdvances in Molecular Diagnostics for Nosocomial Infections (Technical Insights), Technology Adoption Factor AnalysisFactors Influencing the Growth of the IndustryLegal Factors Impacting Nosocomial Infection Diagnostics IndustryOther Growth Accelerating FactorsBarriers to Growth of this SectorStrategic Analysis of Trends and Analyst's Insights Overview of Prevailing TrendsAnalyst's Insights and Strategic RecommendationsStrategic Acquisitions and Partnerships in the Molecular Diagnostics ArenaSWOT MatrixAdvances in Molecular Diagnostics for Nosocomial Infections (Technical Insights), Key Patents and ContactsKey Patents and AnalysisNorth AmericaEuropeAPACGeographical Patent AnalysisKey Industry ParticipantsCorporate ContactsAcademic ContactsAdvances in Molecular Diagnostics for Nosocomial Infections (Technical Insights), Decision Support DatabaseDatabase TablesTotal Healthcare Expenditure--World (1999 to 2006)Government Healthcare Expenditure--World (1999 to 2006)Private Healthcare Expenditure--World (1999 to 2006)Number of Hospitals--World (1999 to 2006)Number of Hospital Beds--World (1999 to 2006)Mortality due to Respiratory Disease--World (1999 to 2006)

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.